Meet the founders of Reclaim October, a grassroots initiative started by breast cancer survivors that aims to change the way ...

Patients with a history of breastfeeding showed higher levels of specialized immune cells in their breasts that may protect ...

A comprehensive review in "Biofunct. Mater." meticulously details the most recent advancements and clinical translation of intelligent nanodrugs for breast cancer treatment.

Breast cancers typically present as hard nodules that feel distinctly different from normal tissue. Other warning signs ...

Mayo Clinic researchers collaborated on a new study led by Eli Lilly showing that the drug abemaciclib improves survival for ...

October is Breast Cancer Awareness month, which means it’s common to see pink ribbons everywhere as health advocates call for ...

Stage 0 cancer, or carcinoma in situ, represents the earliest detectable phase where abnormal cells are confined to their ...

Stage 0 cancer, known as carcinoma in situ, marks the earliest stage of cancer development. Abnormal cells are present but ...

As an avid cyclist and emergency room nurse at Murray-Calloway County Hospital, Kiki Cunningham-Canerdy said that the last ...

For women with in situ breast disease, the 313-single nucleotide polymorphism breast cancer polygenic risk score (PRS313) can predict the likelihood of developing future breast cancer.

Cairn Surgical, Inc., an innovative medical technology firm striving to make breast cancer surgery more precise, announced today that a multicenter study just published in the November issue of the ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines in oncology, today announced that Laura J. Esserman, MD ...